| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/21/2008 | US20080200394 Treatment of Inflammatory Airway Disease |
| 08/21/2008 | US20080200391 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 08/21/2008 | US20080200390 Exendins and Exendin Agonists Modified with Polyamino Acids |
| 08/21/2008 | US20080200389 Rank-ligand-induced sodium/proton antiporter polypeptides |
| 08/21/2008 | US20080200388 Stem cell factor-like proteins and uses thereof |
| 08/21/2008 | US20080200387 Anti-angiogenic protein, composition and use thereof |
| 08/21/2008 | US20080200386 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/21/2008 | US20080200382 Inhibiting of the proliferation of tumor cells is mediated by upregulation of the activity of p53 |
| 08/21/2008 | US20080200378 KGF polypeptide compositions |
| 08/21/2008 | US20080200374 Mutational derivatives of microcin j25 |
| 08/21/2008 | US20080200368 Peptide composition |
| 08/21/2008 | US20080199972 conjugate of the analyte and an europium (or terbium) cryptate fluorophore together with a defined quantity of antibodies which are specific for the analyte, and second antibody which is specific for the fluorophore; fluorescence quenching |
| 08/21/2008 | US20080199964 reconstitute nucleosomes with site-specific mono, di- and trimethylation; (2-chloroethyl)-dimethylammonium chloride; (2-bromoethyl) ammonium bromide; assaying effect of methylation by nucleosome remodeling or octomer reconstitution |
| 08/21/2008 | US20080199952 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity |
| 08/21/2008 | US20080199934 Adding functional groups to peptides for use in preparation of muscle and silk protein |
| 08/21/2008 | US20080199931 Expression vector comprising estrogen signaling protein (IEBP) for use as tool in diagnosis, prevention and treatment of cell proliferative abd bone disorders |
| 08/21/2008 | US20080199919 Plasmid comprising lysine biosynthetic enzymes for use in transforming metnaobacterium into bioreactor for syntesis of lysine and arginine to use in medicine, nutraceuticals and animal foodstuffs |
| 08/21/2008 | US20080199913 Using chinese hamster ovvaries as bioreactor for generation of early Th1 cytokine response regulatory protein; treating inflammatory, cardiovascular, liver and ischemic disorders |
| 08/21/2008 | US20080199912 Methods for Obtaining Optically Active Epoxides and Diols from 2,3-Disubstituted and 2,3-Trisubstituted Epoxides |
| 08/21/2008 | US20080199911 Producing water-soluble protein from chimeric water-insoluble via polypeptide refolding; preparing genetic vaccine for treatment and prevention of viral infection in animal; veterinary medicine |
| 08/21/2008 | US20080199906 Optimized Nucleotide Sequences Encoding Sgp 130 |
| 08/21/2008 | US20080199899 Method For Screening Modulators of Mitochondrial Functioning and New Modulators Obtained |
| 08/21/2008 | US20080199892 Using glycosylation profile thyrotropin as diagnostic indicator of thyroid disorders |
| 08/21/2008 | US20080199888 Follicle stimulating hormone receptor for use in identifying modulators for prevention and treatment of osteoporosis, menopausal, prostate cancer and polycystic ovary syndrome (PCOS) |
| 08/21/2008 | US20080199886 Igf binding proteins |
| 08/21/2008 | US20080199883 Protein kinase (PAPAP) for use in diagnosis, prevention and treatment of nervous system disorders |
| 08/21/2008 | US20080199876 MutS homolog 5 (MSH5) variant for use as diagnostic/ prognostic indicator of cell proliferative disorders |
| 08/21/2008 | US20080199856 Probe for Diagnosis of Marfan Syndrome and a Method for Screening Using the Probe |
| 08/21/2008 | US20080199854 Methods and compositions for identifying RNA-binding proteins |
| 08/21/2008 | US20080199532 Congestive heart failure; induce vasodilation |
| 08/21/2008 | US20080199508 Containing polyglycan and mucopolysaccharides with polypeptides; improve performance of medical device |
| 08/21/2008 | US20080199503 Mixture of oligopeptide and cyclodextrins; model for drug design ; hypotensive agenst; cardiovascular disorders; atherosclerosis; antitumor agenst; antidiabetic agenst |
| 08/21/2008 | US20080199496 Protein disulfide isomerase for therapy, detection, prevention of leishmaniasis; parasiticides |
| 08/21/2008 | US20080199494 Vaccine |
| 08/21/2008 | US20080199492 Env Polypeptide Complexes and Methods Of Use |
| 08/21/2008 | US20080199483 Long lasting fusion peptide inhibitors of viral infection |
| 08/21/2008 | US20080199480 Methods for Identifying Risk of Type II Diabetes and Treatments Thereof |
| 08/21/2008 | US20080199479 Method of treating a muscle-related condition with modified IGF1 polypeptides |
| 08/21/2008 | US20080199477 Human receptor proteins; related reagents and methods |
| 08/21/2008 | US20080199475 Novel glycosylated peptide target in neoplastic cells |
| 08/21/2008 | US20080199474 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199469 Using A20 binding inhibitor of NF- kappa B (ABIN) to stabilize MEK kinase and treat and/or prevent inflammatory diseases |
| 08/21/2008 | US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits |
| 08/21/2008 | US20080199447 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 08/21/2008 | US20080199443 Bone Morphogenetic Variants, Compositions and Methods of Treatment |
| 08/21/2008 | US20080199442 Gene linked to control elements capable of directing in vivo transcription and translation; systemic delivery of erythropoietin |
| 08/21/2008 | US20080199435 IL-8 Like Protein |
| 08/21/2008 | US20080199425 Administering monophenol or benzenediol compounds which modify tyrosinase proteins; stimulate inflammatory response; 4-tertiary butylphenol, fludarabine and cyclophosphamide |
| 08/21/2008 | US20080199424 Mart-1 t cell receptors |
| 08/21/2008 | US20080199422 Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline |
| 08/21/2008 | US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines |
| 08/21/2008 | US20080199398 Polypeptide conjugate comprising helices of ApoA-1 apolipoproteins and peptide linking groups; antiinflammatory domain and/or domain that effects lecithin-cholesterol acyltransferase (LCAT); dyslipidemic disorders, stroke and myocardial infarction; cardiovascular disorders; detecting plaque |
| 08/21/2008 | US20080199396 Radioisotope Labelled Biological Compositions, And Their Use In Accelerator Mass Spectrometry |
| 08/21/2008 | CA2678468A1 Polypeptide comprising a knottin protein moiety |
| 08/21/2008 | CA2678436A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 08/21/2008 | CA2678001A1 Therapeutic application of kazal-type serine protease inhibitors |
| 08/21/2008 | CA2677932A1 Glucagon/glp-1 receptor co-agonists |
| 08/21/2008 | CA2677853A1 Allergen fragments |
| 08/21/2008 | CA2677748A1 Binding members for ige molecules |
| 08/21/2008 | CA2676568A1 Prevention and treatment of sub-clinical pcvd |
| 08/21/2008 | CA2676297A1 Inhibitors of hepatitis c ns3 protease |
| 08/21/2008 | CA2664791A1 Recombinant rhinovirus vectors |
| 08/20/2008 | EP1959018A1 Optimizing glycan processing in plants |
| 08/20/2008 | EP1959017A1 Methods for the production of insulin in plants |
| 08/20/2008 | EP1959015A2 Secreted streptococcus pneumoniae proteins |
| 08/20/2008 | EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use |
| 08/20/2008 | EP1958966A2 Methods for modulating T cell responses by manipulating a common cytokine receptor gamma chain |
| 08/20/2008 | EP1958964A2 RAB9A, RAB11A, and modulators thereof related to infectious disease |
| 08/20/2008 | EP1958963A1 Oxygen-carrying blood substitute preparations |
| 08/20/2008 | EP1958962A2 Artificial antibody polypeptides |
| 08/20/2008 | EP1958961A2 Transport Vectors |
| 08/20/2008 | EP1958960A2 A process for the preparation of a non-toxic anthrax vaccine |
| 08/20/2008 | EP1958959A2 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 08/20/2008 | EP1958958A1 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 08/20/2008 | EP1958957A1 Polypeptide comprising a knottin protein moiety |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1958645A1 Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof |
| 08/20/2008 | EP1958644A1 Prevention and treatment of sub-clinical pcvd |
| 08/20/2008 | EP1958642A1 Regulation of cell growth by MUC1 |
| 08/20/2008 | EP1958503A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 08/20/2008 | EP1957986A2 Intraocular pressure-regulated early genes and uses thereof |
| 08/20/2008 | EP1957650A1 Bioassays |
| 08/20/2008 | EP1957646A1 Compositions and methods for therapy and diagnosis of cancer |
| 08/20/2008 | EP1957638A1 Uses of the fcrn receptor |
| 08/20/2008 | EP1957534A1 Therapeutic vaccines targeting hmgb1 |
| 08/20/2008 | EP1957532A1 Methods and reagents for elimination or reduction of false positives in the analysis of a sample |
| 08/20/2008 | EP1957529A1 Receptor-specific tumour necrosis factor-related apoptosis-inducing ligand (trail) variants |
| 08/20/2008 | EP1957528A2 A nucleotide vaccine |
| 08/20/2008 | EP1957527A2 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| 08/20/2008 | EP1957526A1 Molecules inhibition intercellular adhesion |
| 08/20/2008 | EP1957525A2 Keratin-binding effector molecules containing reactive dyes |
| 08/20/2008 | EP1957524A1 Targeted fusion proteins for cancer therapy |
| 08/20/2008 | EP1957523A1 Conditionally-immortalised pancreatic cells |
| 08/20/2008 | EP1957522A2 AVß6 PEPTIDE LIGANDS AND THEIR USES |
| 08/20/2008 | EP1957520A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 08/20/2008 | EP1957519A1 Production and use of highly functional, highly branched or hyperbranched polylysines |
| 08/20/2008 | EP1957103A2 Bacterial vaccine against bacterial infective agents, to be used in animals |
| 08/20/2008 | EP1957034A2 Chimeric keratin-binding effector proteins |
| 08/20/2008 | EP1844065A4 Polypeptide having function related to pyridoxine biosynthesis, polynucleotide coding the polypeptide, and those use |